Group A Streptococcus antigens (GAS antigens) (GAS antigens)

Group A Streptococcus (GAS) antigens are a collection of structural and secreted molecules from the bacterium Streptococcus pyogenes that play pivotal roles in pathogenesis and are the primary focus of vaccine and diagnostic development (CDC, 2023). The most prominent antigen is the M protein, a surface-anchored fibrillar protein that inhibits phagocytosis and facilitates adhesion to host tissues (StatPearls, 2023). Other critical antigens include the Group A Carbohydrate (GAC), which is a conserved component of the cell wall, and secreted virulence factors such as streptolysin O and pyrogenic exotoxins (WHO, 2021). These antigens are targeted by the host immune system, and their detection is central to diagnosing infections like strep throat and impetigo. In therapeutic development, GAS antigens are used in various vaccine platforms—including recombinant proteins and conjugate vaccines—to prevent severe invasive diseases and post-streptococcal sequelae like rheumatic heart disease (Vaxcyte, 2024). However, the high degree of antigenic variation among the 200+ emm types of M protein and the risk of inducing autoimmune cross-reactivity remain significant hurdles in drug design (PubMed, 2022).

Other names

Streptococcus pyogenes antigensGAS antigensGroup A beta-hemolytic Streptococcus antigens

Vaccines target GAS antigens to induce opsonophagocytic antibodies and T-cell responses to prevent colonization and infection. Passive immunization with IVIG neutralizes streptococcal pyrogenic exotoxins and enhances bacterial clearance (PubMed, 2022).